HLCS Antikörper
Kurzübersicht für HLCS Antikörper (ABIN2716652)
Target
Alle HLCS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Homo sapiens holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase) (HLCS), transcript variant 1
-
Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Full length human recombinant protein of human HLCS(NP_000402) produced in HEK293T cell.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- WB 1:2000, IHC 1:150, FLOW 1:100,
-
Kommentare
-
The concentration of the product may vary between diferrent lots.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
- HLCS (Biotin-Protein Ligase (HLCS))
-
Andere Bezeichnung
- HLCS
-
Hintergrund
- This gene encodes an enzyme that catalyzes the binding of biotin to carboxylases and histones. The protein plays an important role in gluconeogenesis, fatty acid synthesis and branched chain amino acid catabolism. Defects in this gene are the cause of holocarboxylase synthetase deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified.
-
Molekulargewicht
- 80.6 kDa
-
Gen-ID
- 3141
-
NCBI Accession
- NM_000411
-
HGNC
- 3141
Target
-